Cost, staffing, unbiased training data, and strong referral partnerships will decide whether AI eye screening reaches patients at highest risk of vision loss.
Grayson W. Armstrong, MD, MPH
Advertisement
Grayson W. Armstrong, MD, MPH, director, Massachusetts Eye and Ear.
Articles by Grayson W. Armstrong, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
2
5 Things to Know if Retatrutide Is Classified as a Biologic
3
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
4
NEI Director Highlights Pediatric Advances, AI’s Promise in Eye Care
5